A passenger with a severe nut allergy claims he was denied boarding after an emergency diversion on an easyJet flight, resulting in more than £3,000 in additional costs to return home.
A passenger aboard an easyJet flight from Malaga to Belfast experienced a severe reaction due to his nut allergy, leading to an emergency diversion to Brest, France. Upon landing, medical personnel attended to him and he was discharged after receiving care. However, the airline's assertion that he was cleared to continue his journey clashed with the passenger's experience, who contends that he was denied re-boarding the flight despite presenting all required medical clearances.
The passenger reported significant frustration over easyJet's handling of the situation, stating that he was left stranded in France with no assistance and had to spend over £3,000 to arrange alternative travel back home to Belfast. He highlighted that this incident has not only caused him financial strain but also considerable stress, emphasizing that he complied with all necessary protocols regarding his allergy prior to boarding.
This incident showcases potential oversight in airline policies regarding passengers with severe allergies, suggesting a gap between medical clearance and actual re-boarding permissions. The fallout from such incidents raises questions about broader airline operational practices, particularly how they support passengers with specific health needs during unforeseen circumstances.
